Quest Diagnostics (DGX) EBT Margin (2009 - 2026)

Quest Diagnostics has reported EBT Margin for 18 years, with the latest figure at 13.54% in Q2 2026.

• Quarterly EBT Margin fell 37.0% year-over-year to 13.54% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 12.15% (up 22.0% YoY) and the FY2025 annual result came in at 11.94%, up 4.0% from the prior year.
• EBT Margin improved to 13.54% in Q2 2026 per DGX's latest filing, from 11.54% in the prior quarter.
• Over five years, EBT Margin peaked at 17.31% in Q1 2022 and troughed at 4.67% in Q4 2022.
• A 5-year average of 12.14% and a median of 11.89% in 2024 frame the typical range for EBT Margin.
• The sharpest annual moves came in 2022 and 2023: EBT Margin sank 1887 bps in 2022, then jumped 569 bps in 2023.
• Over 5 years, EBT Margin stood at 4.67% in 2022, then jumped by 122 bps to 10.36% in 2023, then advanced by 10 bps to 11.41% in 2024, then increased by 3 bps to 11.76% in 2025, then gained by 15 bps to 13.54% in 2026.
• According to Business Quant data, EBT Margin over the past three periods registered 13.54%, 11.54%, and 11.76% for Q2 2026, Q1 2026, and Q4 2025 respectively.